Company Filing History:
Years Active: 2017
Title: Innovations in Neurological Treatments: The Contributions of Päivi Pulkkila
Introduction: Päivi Pulkkila, a prominent inventor based in Sipoo, Finland, has made significant contributions to the field of neuroscience. With a focus on addressing neuronal disorders, Pulkkila's work has the potential to impact countless lives afflicted by various neurological conditions.
Latest Patents: He holds a notable patent for the invention titled "Neurotrophic factor MANF and uses thereof." This groundbreaking invention centers on the treatment of neuronal disorders, specifically targeting peripheral neuropathies such as Alzheimer's disease, Parkinson's disease, epilepsy, drug addiction, and ischemic brain injury. The patent encompasses a pharmaceutical compound that includes a MANF nucleic acid molecule, MANF protein, or a functional fragment thereof, showcasing his innovative approach to combating debilitating neurological diseases.
Career Highlights: Päivi Pulkkila works with Herantis Pharma Plc., a company dedicated to advancing therapies for neurological and other serious medical conditions. His endeavors in research and patent formulation underline his commitment to enhancing treatment methodologies in the medical field.
Collaborations: Throughout his career, Pulkkila has collaborated with esteemed colleagues such as Mart Saarma and Merja Voutilainen. These partnerships reflect his integration into a network of innovators and researchers dedicated to tackling complex health issues through collaborative efforts.
Conclusion: Päivi Pulkkila stands out in the realm of inventors with his significant contributions to neurobiology. His work not only holds promise for advancing treatment options but also emphasizes the importance of innovation in addressing the challenges presented by neurological disorders. Through his patent and ongoing collaborations, Pulkkila continues to pave the way for future advancements in the field.